Patent ID: 8445018

Claim:
An abuse resistant tablet consisting of: a. a plurality of coated granules, wherein each coated granule consists of: i. a granule consisting of: a. an opioid, and/or a salt thereof, present in an amount in the range of from 20 to 60 percent by weight of the uncoated granule; b. ethylcellulose present in an amount in the range of from 10 to 75 percent by weight of the uncoated granule; c. hydroxypropyl methyl cellulose present in an amount in the range of from 15 to 50 percent by weight of the uncoated granule; and ii. a coating substantially surrounding the granule, wherein the coating consists of: a. ethyl cellulose present in an amount in the range of from 20 to 60 percent by weight of the coated granule; b. glyceryl behenate present in an amount in the range of from 10 to 30 percent by weight of the coated granule; wherein the plurality of coated granules are present in the tablet in an amount to provide a therapeutically effective amount of the hydrocodone, and/or a salt thereof; and b. a matrix composition consisting of: i. hydroxypropyl methyl cellulose present in an amount in the range of from 2 to 20 percent by weight of the tablet; ii. lactose present in an amount in the range of from 10 to 75 percent by weight of the tablet; and iii. magnesium stearate present in an amount in the range of from 0.25 to 2 percent by weight of the tablet.